Warning letter
Cosmax NBT USA: warning letter of May 3, 2023
FDA warning letter 615933 · Division of Human and Animal Food Operations West III
Key facts
| Reference number | 615933 |
|---|---|
| Company | Cosmax NBT USA |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | May 3, 2023 |
| Posted date | Aug 29, 2023 |
| Issuing office | Division of Human and Animal Food Operations West III |
| Product type | Food/Cosmetics |
| CFR sections cited | 101, 101.4, 101.36, 111, 111.70(b), 111.70(b)(1), 111.70(b)(2), 111.70(e), 111.75(h)(1), 111.95(b)(1), 101.36(b), 101.36(b)(2)(i) and 7 more |
| Inspection city | Garland |
| Inspection ZIP | 75042 |
| Inspection start date | Apr 6, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: